Envista Holdings Corporation (NYSE: NVST) |
|
Price: $20.5700
$0.44
2.186%
|
Day's High:
| $21
| Week Perf:
| -3.92 %
|
Day's Low: |
$ 20.35 |
30 Day Perf: |
8.09 % |
Volume (M): |
4,922 |
52 Wk High: |
$ 24.79 |
Volume (M$): |
$ 101,243 |
52 Wk Avg: |
$19.22 |
Open: |
$20.45 |
52 Wk Low: |
$15.15 |
|
|
Market Capitalization (Millions $) |
3,557 |
Shares
Outstanding (Millions) |
173 |
Employees |
9,800 |
Revenues (TTM) (Millions $) |
2,502 |
Net Income (TTM) (Millions $) |
-1,337 |
Cash Flow (TTM) (Millions $) |
167 |
Capital Exp. (TTM) (Millions $) |
33 |
Envista Holdings Corporation
Envista Holdings Corporation is a global dental products and technology company that operates in more than 60 countries worldwide. The company was originally founded in 1985 as a dental imaging business and has since expanded its range of products and services to cover a wide spectrum of dental practices.
Envista Holdings Corporation is the parent company of multiple subsidiaries, including KaVo Kerr, Nobel Biocare, Consumables Solutions, Ormco and Rodo Medical. These subsidiaries are involved in the manufacturing and distribution of a diverse range of dental products, such as dental equipment, consumables, implants, orthodontics, and imaging products.
KaVo Kerr, one of the company's biggest subsidiaries, is a leading provider of dental equipment and supplies. They offer a wide range of products, such as handpieces, prophy systems, imaging systems, and dental lab equipment. Nobel Biocare is another subsidiary of Envista which specializes in dental implants and excellent technical solutions.
Consumables Solutions offers an extensive range of high-quality disposable dental products such as syringes, gloves, masks, and saliva ejectors. It is focused on creating innovative and affordable disposable products for dental professionals. Ormco and Rodo Medical focus extensively on developing smart orthodontic solutions while keeping in mind periodontal diseases.
Envista Holdings Corporation also offers advanced dental technologies and software solutions to facilitate better patient outcomes. They have introduced various innovative and intuitive software technologies such as DentMate, an online practice management tool and Guided Surgery Software which is utilized for better diagnostic and medical imaging purposes.
Overall, Envista Holdings Corporation is committed to providing advanced dental solutions that enhance patient health and well-being, as well as making dental practices more productive, efficient and profitable. Their extensive range of dental products and technologies are designed to meet the diverse needs of dental practices of all sizes, levels and areas of specialization.
Company Address: 200 S. Kraemer Blvd., Building E Brea, 92821 CA
Company Phone Number: 817-7000 Stock Exchange / Ticker: NYSE NVST
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Envista Holdings Corporation
Envista Holdings Corporation (NVST) has experienced a significant decline in earnings and revenue in the financial period ending March 29, 2024. With earnings per share decreasing by -44% to $0.14 and revenue dropping by -0.622% to $623.30 million year on year, it is clear that the company is facing some serious challenges. In comparison to the overall Medical Equipment & Supplies industry, which recorded a revenue gain in the first quarter of 2024, NVST's performance is lackluster. The company's net income of $23.600 million in the financial period ending March 29, 2024 fell by -46.12% from the previous year, highlighting a concerning trend of declining profitability.
|
Envista Holdings Corporation
Envista Holdings Corporation, a leading Medical Equipment & Supplies company, recently reported its financial results for the fourth quarter of 2023. The company experienced a slip into a loss of $-1.27 per share compared to $0.42 per share the previous year. Additionally, the EPS fell from $0.12 per share from the previous quarter. In terms of revenue, Envista saw a decrease of -2.3% to $645.60 million from $660.80 million in the comparable quarter the prior year. However, sequentially, the company experienced a 2.265% growth in revenue from $631.30 million in the previous quarter. The net loss for the fourth quarter of 2023 was $-217.400 million, a substantial decrease from the net proceeds of $73.500 million in the same quarter the previous year.
|
Envista Holdings Corporation
Envista Holdings Corporation experienced a slight rise in revenue of 0.032% in the Sep 29 2023 report, reaching $631.30 million. However, this increase was unable to prevent a significant decline in income of -55.56% compared to the corresponding reporting season in the previous year. Despite this decline, Envista Holdings Corporation's revenue growth remained below that of its contemporaries in the Medical Equipment & Supplies industry, which reported an average rise of 0.80% in Q3 of 2022. In comparison to the preceding reporting season, profits plummeted by -58.62% from $0.29 per share, and revenue decreased by -4.695% from $662.40 million. The bottom-line of $21.500 million in the July to September 29 2023 period fell by -54.83% from $47.600 million in the same period a year before. These figures indicate a challenging financial environment for Envista Holdings Corporation during this reporting season.
|
Envista Holdings Corporation
Envista Holdings Corporation, a leading provider of medical equipment and supplies, recently published its financial results for the period ending June 30, 2023. The company showcased a moderate revenue improvement of 2.57%, reaching $662.40 million, outpacing its sector peers. Additionally, Envista demonstrated growth in income per share, with a year-on-year increase of 11.54% to $0.29. These financial results indicate a positive trajectory for the company. Revenue Improvement and Outperformance: Envista Holdings Corporation's revenue growth of 2.57% in the financial period ending June 30, 2023, demonstrates its ability to outpace its competitors in the Medical Equipment & Supplies sector. In the same period, the sector's average revenue improvement was only 0.99%. This highlights Envista's strength in achieving top-line growth. Furthermore, Envista experienced a substantial increase in revenue compared to the previous period, with a growth rate of 5.612% from $627.20 million. This growth can be attributed to the company's effective operational strategies and successful management of market demands.
|
Envista Holdings Corporation
Envista Holdings Corporation faces a challenging situation with a reported decrease in its earnings per share and revenue in the financial period ending March 31, 2023. Despite these results, there are opportunities to remain optimistic about the future of this company. Firstly, Envista Holdings Corporation demonstrated a return on equity rate of 5.15%, which is above average when compared to the industry's average return on equity of 4.78%. Envista Holdings Corporation was able to beat the industry average despite some obstacles, such as the decline in net income. There is also an opportunity for Envista Holdings Corporation to bounce back from its current downturn, with a higher ranking in the overall return on equity for the first quarter of 2023. This ranking has improved, putting the company in 1484th place, in comparison to the 1764th place in the fourth quarter of 2022. Although Envista Holdings Corporation experienced a decline in net income, its operating earnings still amounted to $72.1 million for the first quarter of 2023. While this may not be as high as in the previous year, this figure is still noteworthy in the face of the current economic climate.
|
Per Share |
Current |
Earnings (TTM) |
-7.77 $ |
Revenues (TTM) |
14.47 $
|
Cash Flow (TTM) |
0.97 $ |
Cash |
5.73 $
|
Book Value |
17.77 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
-7.77 $
|
Revenues (TTM) |
14.47 $ |
Cash Flow (TTM) |
0.97 $ |
Cash |
5.73 $
|
Book Value |
17.77 $ |
Dividend (TTM) |
0 $ |
|
|
|
North America |
|
53.22 % |
of total Revenue |
Western Europe |
|
18.21 % |
of total Revenue |
Other developed markets |
|
5.21 % |
of total Revenue |
Emerging markets |
|
23.47 % |
of total Revenue |
Specialty Products Technologies |
|
63.58 % |
of total Revenue |
Specialty Products Technologies North America |
|
27.54 % |
of total Revenue |
Specialty Products Technologies Western Europe |
|
14.19 % |
of total Revenue |
Specialty Products Technologies Other developed markets |
|
3.61 % |
of total Revenue |
Specialty Products Technologies Emerging markets |
|
18.24 % |
of total Revenue |
Equipment Consumables |
|
36.53 % |
of total Revenue |
Equipment Consumables North America |
|
25.69 % |
of total Revenue |
Equipment Consumables Western Europe |
|
4.01 % |
of total Revenue |
Equipment Consumables Other developed markets |
|
1.6 % |
of total Revenue |
Equipment Consumables Emerging markets |
|
5.23 % |
of total Revenue |
Specialty Products Technologies segments |
|
63.58 % |
of total Revenue |
Equipment Consumables segments |
|
36.53 % |
of total Revenue |
|
|